Health TrialsbyHealthPanel

Stroke, Cryptogenic

2

Review clinical trials related to Stroke, Cryptogenic. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

NeuroAiD Patient-Reported Outcomes in Patients With Mild to Moderate Ischemic Stroke

This is a randomized, controlled, open-label study of MLC901 (NeuroAiD™ II) in patients with mild to moderate ischemic stroke. Eligible participants will be randomized in a 1:1 ratio to receive MLC901 in combination with standard treatment or standard treatment alone for 12 weeks.

Participants needed: 80
Trial details
Phase: Phase 4Age: 18-80Biological sex: AllType: InterventionalSponsor: EVD Pharmacy and Medical Company LimitedUpdated: Sep 30, 2026Locations: 1
Eligibility criteria

Male or female. [+6]

Hemorrhagic stroke. [+10]

Read more
Status: Not yet recruiting

MLC1501 Study Assessing Efficacy in STROke Recovery

This is a multi-center, randomized, double-blind, placebo-controlled, dose-response study of MLC1501 in patients with stroke. Eligible participants will be randomized in a 1:1:1 ratio to orally receive MLC1501 low-dose twice a day, MLC1501 high-dose twice a day, or matching placebo for 24 weeks.

Participants needed: 540
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Moleac Pte Ltd.Updated: Mar 16, 2023
Eligibility criteria

Male or female. [+5]

Pre-stroke modified Rankin score of >1. [+8]

Read more